The calcium ion (Ca 2+ ) plays a fundamental role in a number of physiological functions including bone formation, muscle contraction, secretion, enzyme cofactor, stabilization of membrane potentials, blood coagulation, etc. Calcium is homeostatically regulated by hormones that determines calcium balance within the body. The hormones PTH, 1,25-(OH)2D3 and calcitonin are altered in endocrine cancers which are in turn regulated by calcium. The main focus of this review is how hormones can regulate calcium homeostasis in endocrine cancers.
iNTRoduCTioN importance of Calcium in Biological System
Calcium (Ca 2+ ) is a useful ubiquitous ion in biology. It has an oxidation state of +2 which gives greater strength in interacting with anionic complexes compared to sodium, potassium or other monocations. Ca 2+ is the fifth most abundant element in the body but 99% of it is sequestered in bone. Among the roles for Ca 2+ , a major role is acting as a secondary signal to convert signals from the extracellular environment into specific intracellular responses. Also, Ca 2+ is involved in the rapid depolarization of cells in neurons and muscle cells. These actions need to be tightly controlled. Therefore, Ca 2+ is kept at low levels in the cell's cytosol 
Major Hormones which take Part in Calcium Homeostasis
In endocrine cancers, the major hormones which are altered mainly include PTH, 1,25-(OH)2D3 and calcitonin. The extracellular fluid (or plasma) calcium concentration is tightly controlled by a complex homeostatic mechanism involving fluxes of calcium between the extracellular fluid (ECF) and the kidney, bone, and gut. These fluxes are carefully regulated by three major hormones: parathyroid hormone (PTH), calcitonin, and 1,25-dihydroxyvitamin D[1,25(OH)2D3]. Important cellular functions are dependent on the maintenance of the extracellular calcium concentration within a narrow range. 3 Since, these enzymes play a major part in the calcium homeostasis, it is important to give a crosstalk on the alterations in calcium homeostasis of these hormones due to occurrence endocrine cancers.R
ole of Calcium through Hormonal Regulation in different Endocrine Cancers
The major endocrine cancers in which the calcium signaling is altered by the hormonal regulation are prostate cancer, parathyroid cancer and breast cancer. Cancer that forms in tissues of the prostate (a gland in the male reproductive system found below the bladder and in front of the rectum). Prostate cancer usually occurs in older men. Parathyroid cancer is a rare cancer that forms in tissues of one or more of the parathyroid glands (four pea-sized glands in the neck that make parathyroid hormone, which helps the body store and use calcium). The most common type of breast cancer is ductal carcinoma, which begins in the lining of the milk ducts (thin tubes that carry milk from the lobules of the breast to the nipple). Another type of breast cancer is lobular carcinoma, which begins in the lobules (milk glands) of the breast.
In prostate cancer, PTH plays a mitogen role through alterations in calcium homeostasis. There are several studies on breast cancer and prostate cancer with its relation to PTH and 1,25(OH)2D. In most of other endocrine cancers the changes in calcium homeostasis with respect to PTH, 1,25(OH)2D and calcitonin is well studied. The main focus of this review is how hormones can regulate calcium homeostasis in endocrine cancers.
Role of PTH-dependent Calcium Homeostasis in different Endocrine Cancer
In 1962, Ludwig observed that metastases from prostate cancer cause increased serum levels of PTH. However, the epidemiologic and clinical implications of that observation have been little appreciated, PTH is now understood to be a mitogen for prostate cancer cells. 4 In case of prostate cancer serum, PTH levels are very high and it promotes the progression of prostate cancer in bones. There are several studies on the role of PTH on CaR modulations in Ca 2+ homeostasis.
Some studies show increased bone turnover produced by PTH helps to increase prostate cancer metastasis to bone 5 and the bone re-absorption induced by the dietary deficiency of calcium leads to the bony metastasis. The PTHrP is believed to be a mediator for 70% of breast and prostate cancer: (1) higher PTHrP expression in prostatic dysplasia (prostate intraepithelial neoplasia) than in normal prostate epithelium and (2) higher PTHrP expression in prostate carcinoma than in benign hyperplasia suggests that there are promalignant or proliferative effects of PTHrP that participate in the pathophysiology of prostate cancer. [6] [7] [8] In normal breast cells, similarly to PTH release, the secretion of PTHrP is inhibited by increase in the Ca 2+ concentra- ) appears to be sufficient to elicit apoptosis.
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In parathyroid adenomas Ca 2+ levels and 1,25(OH)2D3 negatively regulate PTH synthesis and parathyroid proliferation through the activation of vitamin D receptor (VDR).
Calcitonin
Calcitonin is a hormone known to participate in calcium and phosphorus metabolism. In mammals, the major source of calcitonin is from the parafollicular or C cells in the thyroid gland. Calcitonin regulates the blood calcium levels. Calcitonin is used as a tumor marker for medullary thyroid cancers. Increase in ionized calcium enhances release of wjoes calcitonin. Clinical observations support the notion that calcitonin has little chronic effect, because neither calcitonindeficient patients (athyroid) nor patients with medullary thyroid cancer and excess calcitonin production experience alterations in calcium homeostasis. The calcitonin receptor has been cloned 24 and is structurally similar to the PTH receptor in that it also has seven transmembrane domains. Calcitonin is metabolized in minutes in the circulation, predominantly in the kidney. The calcitonin receptor is related structurally to the PTH/PTH-rP and secretin receptors. The calcitonin receptor exists in several isoforms, and its expression seems to be influenced by ambient concentrations of calcitonin itself. This may be the reason for down-regulation of the receptor and the escape phenomenon that occurs in the continued presence of calcitonin. -mediated signaling pathways have also been shown to play important roles in carcinogenesis, such as transformation of normal cells to cancerous cells, tumor formation and growth, invasion, angiogenesis and metastasis. The transformation of a normal cell into a malignant derivative is associated with a major rearrangement of Ca 2+ pumps, Na/Ca exchangers and Ca 2+ channels, which leads to enhanced proliferation and invasion under compromised/impaired ability to die. Parathyroid hormone is the major hormone which plays a role in many endocrine cancers through altering the calcium signaling. PTH mediated cancers are regulated by the calcium homeostasis at times. It is very important to go deep into the molecular mechanism of PTH hormone actions and Ca 2+ homeostasis, because it can help in the drug development and cancer treatment. The protective nature of 1,25(OH)2D3 is also very important in the treatment and curing of endocrine cancers. 1,25(OH)2D3 acts through the regulation of PTH and regulates calcium levels in blood. It has also got a major role in apoptosis in breast cancer. Calcitonin regulates the blood Ca 2+ levels. In conclusion better management of the hormonal level can probably become a treatment for the endocrine cancers.
